Contribution of individual toxin components to virulence of Bacillus anthracis

Three proteins, protective antigen (PA), lethal factor (LF), and edema factor (EF; a calmodulin-dependent adenylate cyclase), compose the lethal (PA + LF) and edema (PA + EF) toxins secreted by Bacillus anthracis. Mutant strains, each deficient in the production of one toxin component, were constructed, and their virulence was then studied. A kanamycin resistance cassette was inserted in each cya (encoding EF) and lef (encoding LF) gene, and the constructs were separately introduced into B. anthracis Sterne on a mobilizable shuttle plasmid. An EF- strain and an LF- strain were then isolated after homologous recombination with the resident toxin-encoding plasmid, pXO1. Spores from these mutants and from a previously constructed PA- mutant were used to inoculate mice, and the lethality and local edema formation were monitored. LF- or PA- mutants were not lethal even at high inocula, whereas the EF- mutant induced lethal infections. This indicates that LF in combination with PA is a key virulence factor required for lethality. Skin edema formation was observed with the LF- mutant, which produces only the combination of PA and EF. However, EF- and LF- mutants were significantly less efficient at inducing, respectively, lethality and edema than was the parental Sterne strain. These results suggest that the three toxin components might act synergistically in vivo to cause lethality and edema formation.

[1]  C. B. Thorne,et al.  RAPID LETHAL EFFECT IN RATS OF A THIRD COMPONENT FOUND UPON FRACTIONATING THE TOXIN OF BACILLUS ANTHRACIS , 1962, Journal of bacteriology.

[2]  S. Welkos,et al.  Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. , 1988, Microbial pathogenesis.

[3]  B. G. Mahlandt,et al.  Purification and Properties of In Vitro–produced Anthrax Toxin Components , 1968, Journal of bacteriology.

[4]  J. Walker,et al.  Pathophysiological changes in the rat associated with anthrax toxin. , 1968, The Journal of infectious diseases.

[5]  J. Ezzell,et al.  Effects of anthrax toxin components on human neutrophils , 1985, Infection and immunity.

[6]  H. B. Stoner,et al.  Anthrax toxic complex. , 1967, Federation proceedings.

[7]  B. Ivins,et al.  Evidence for plasmid-mediated toxin production in Bacillus anthracis , 1983, Infection and immunity.

[8]  S. Welkos,et al.  Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. , 1988, Microbial pathogenesis.

[9]  S. Welkos,et al.  Differences in susceptibility of inbred mice to Bacillus anthracis , 1986, Infection and immunity.

[10]  H. Smith,et al.  Purification of factor I and recognition of a third factor of the anthrax toxin. , 1961, Journal of general microbiology.

[11]  S. Leppla,et al.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Trieu-Cuot,et al.  Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. , 1983, Gene.

[13]  A. Danchin,et al.  Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. , 1988, Gene.

[14]  P. Hambleton,et al.  Anthrax: the disease in relation to vaccines. , 1984, Vaccine.

[15]  D. Storm,et al.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases. , 1987, Microbiological reviews.

[16]  D. Ladant,et al.  Interaction of Bordetella pertussis adenylate cyclase with calmodulin. Identification of two separated calmodulin-binding domains. , 1988, The Journal of biological chemistry.

[17]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[18]  C. Yanisch-Perron,et al.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.

[19]  M. Mock,et al.  Construction and characterization of a protective antigen‐deficient Bacillus anthracis strain , 1990, Molecular microbiology.

[20]  S. Leppla Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[21]  I. Uchida,et al.  Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. , 1985, Journal of general microbiology.

[22]  P. Trieu-Cuot,et al.  Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria. , 1991, Gene.

[23]  S. Welkos,et al.  Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. , 1988, Gene.

[24]  C. B. Thorne,et al.  Demonstration of a capsule plasmid in Bacillus anthracis , 1985, Infection and immunity.

[25]  L. Katz,et al.  Structure and Composition of the Bacillus anthracis Capsule , 1965, Journal of bacteriology.

[26]  M. Sterne The immunization of laboratory animals against anthrax , 1939 .

[27]  A. Danchin,et al.  Structural homology between virulence-associated bacterial adenylate cyclases. , 1988, Gene.

[28]  A. Gilles,et al.  Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase. , 1990, Biochemistry.

[29]  A. Friedlander,et al.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. , 1986, The Journal of biological chemistry.

[30]  D. Robertson,et al.  Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. , 1989, Gene.

[31]  Jeffrey H. Miller Experiments in molecular genetics , 1972 .

[32]  S. Leppla Production and purification of anthrax toxin. , 1988, Methods in enzymology.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.